Metviron Trio 1 Tablet ER
Metviron Trio 1 Tablet ER
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹20
that's 39% off!
About This Medicine
Product description & overview
Metviron Trio 1 Tablet ER: A Comprehensive Diabetes Treatment
Metviron Trio 1 Tablet ER (Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg) is a once-daily, extended-release formulation designed for effective blood sugar management in adults with type 2 diabetes mellitus. This unique medication addresses multiple aspects of glucose regulation:
* Glimepiride: A sulfonylurea that stimulates insulin secretion from the pancreas, directly lowering blood sugar levels.
* Metformin: A first-line choice for managing glucose levels by decreasing hepatic glucose production and enhancing insulin sensitivity.
* Voglibose: A selective α-glucosidase inhibitor, inhibiting the breakdown of carbohydrates in the gut, thereby preventing their absorption into the bloodstream and further reducing blood sugar spikes.
By combining these three active ingredients, Metviron Trio offers a comprehensive approach to managing type 2 diabetes, promoting both insulin sensitivity and glucose control within a single dose. This makes it an efficient and convenient option for patients seeking simplified daily management of their condition.
Note: This medication should only be taken as prescribed by your doctor.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Metviron Trio 1 Tablet ER.
High Risk
Pregnancy
Metviron Trio 1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Metviron Trio 1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Metviron Trio 1 Tablet ER may be needed. Please consult your doctor. Metviron Trio 1 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Metviron Trio 1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Metviron Trio 1 Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metviron Trio 1 Tablet ER is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Metviron Trio 1 Tablet ER
Products matching your search
Justmet Safe 2 Tablet ER
Justmet Safe 2 Tablet ER
Enzolid 600 Tablet
Enzolid 600 Tablet
Glycilock Trio Forte 2 Tablet SR
Glycilock Trio Forte 2 Tablet SR
Imezemic 500 Tablet
Imezemic 500 Tablet
Zoryl-MF 2 Tablet PR
Zoryl-MF 2 Tablet PR
Edinase-D Tablet
Edinase-D Tablet
Metviron Trio 2mg Tablet
Metviron Trio 2mg Tablet
Clozostrong-DP Dusting Powder